3rd Annual CKD3 Summit

Evvnt Promotion / evvnt
Archivio
-
02.03.2021 - 04.03.2021  Online
Time: 10:00 - 17:00
 
Temi della conferenza
Overcome the translational challenges limiting the development of the next generation of CKD therapeutics. For the 3rd year, the Chronic Kidney Disease Drug Development Summit (CKD3) is putting the hottest topics in CKD drug development under the spotlight.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
URL:
Brochure: https://go.evvnt.com/613460-3?pid=4832

Speakers: Andrew King, Head of Renal Discovery and Translational Medicine, Chinook Therapeutics, Beno Freedman, Assistant Professor, Nephrology, University of Washington and more.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/613460-2?pid=4832
Mr. Customer Service
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
USD 420.0 - USD 2720.0
I partecipanti attesi
1000
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Ärzte der WeltHelix - Forschung & Beratung WienÖsterreichische Gesellschaft für Public HealthAlumni Club Medizinische Universität WienEuropean Public Health Association (EUPHA)AGEM - Arbeitsgemeinschaft Ethnologie und MedizinSwiss Tropical and Public Health InstitutenewTree